Shares

20 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 07, 2024

BUY
$70.96 - $82.35 $15,398 - $17,869
217 Added 1.75%
12,622 $1.01 Million
Q2 2024

Aug 06, 2024

BUY
$62.12 - $84.15 $29,941 - $40,560
482 Added 4.04%
12,405 $888,000
Q1 2024

Apr 29, 2024

BUY
$65.98 - $77.09 $1,979 - $2,312
30 Added 0.25%
11,923 $839,000
Q4 2023

Jan 18, 2024

SELL
$52.83 - $78.22 $105,184 - $155,736
-1,991 Reduced 14.34%
11,893 $917,000
Q3 2023

Oct 18, 2023

BUY
$67.52 - $89.42 $18,568 - $24,590
275 Added 2.02%
13,884 $945,000
Q2 2023

Aug 10, 2023

BUY
$73.76 - $85.98 $10,473 - $12,209
142 Added 1.05%
13,609 $1.11 Million
Q1 2023

Apr 26, 2023

SELL
$71.62 - $86.62 $34,664 - $41,924
-484 Reduced 3.47%
13,467 $999,000
Q4 2022

Jan 23, 2023

BUY
$80.67 - $352.29 $852,036 - $3.72 Million
10,562 Added 311.66%
13,951 $0
Q3 2022

Nov 07, 2022

BUY
$282.54 - $391.85 $9,323 - $12,931
33 Added 0.98%
3,389 $962,000
Q2 2022

Jul 26, 2022

SELL
$322.67 - $449.65 $9,034 - $12,590
-28 Reduced 0.83%
3,356 $1.16 Million
Q1 2022

Apr 12, 2022

SELL
$353.85 - $487.79 $6,369 - $8,780
-18 Reduced 0.53%
3,384 $1.47 Million
Q4 2021

Jan 18, 2022

BUY
$456.15 - $525.06 $82,107 - $94,510
180 Added 5.59%
3,402 $1.76 Million
Q3 2021

Oct 07, 2021

BUY
$444.87 - $538.88 $10,232 - $12,394
23 Added 0.72%
3,222 $1.56 Million
Q1 2021

Apr 29, 2021

SELL
$314.62 - $411.0 $943 - $1,233
-3 Reduced 0.09%
3,199 $1.22 Million
Q4 2020

Jan 29, 2021

BUY
$246.9 - $321.87 $15,554 - $20,277
63 Added 2.01%
3,202 $1.02 Million
Q3 2020

Oct 29, 2020

BUY
$232.22 - $282.96 $9,056 - $11,035
39 Added 1.26%
3,139 $778,000
Q1 2020

Apr 28, 2020

BUY
$161.17 - $221.51 $805 - $1,107
5 Added 0.16%
3,100 $588,000
Q3 2019

Oct 31, 2019

SELL
$183.56 - $216.72 $9,178 - $10,836
-50 Reduced 1.59%
3,095 $606,000
Q4 2017

Jan 17, 2018

BUY
$121.17 - $134.75 $5,573 - $6,198
46 Added 1.48%
3,145 $440,000
Q3 2017

Oct 23, 2017

BUY
$113.59 - $123.78 $352,015 - $383,594
3,099
3,099 $375,000

Others Institutions Holding TECH

About BIO-TECHNE Corp


  • Ticker TECH
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 39,222,600
  • Market Cap $2.95B
  • Description
  • Bio-Techne Corporation, together with its subsidiaries, develops, manufactures, and sells life science reagents, instruments, and services for the research and clinical diagnostic markets worldwide. The company operates through two segments, Protein Sciences, and Diagnostics and Genomics. The Protein Sciences segment develops and manufactures bi...
More about TECH
Track This Portfolio

Track Caprock Group, Inc. Portfolio

Follow Caprock Group, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Caprock Group, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Caprock Group, Inc. with notifications on news.